Table 1 Clinical characteristics of esophageal cancer patients diagnosed at AUBMC between 1995 and 2019
Factor | n (%) | |
|---|---|---|
Presenting signs and symptoms a (n = 101) | Dysphagia | 85 (84.2%) |
Weight loss | 62 (61.3%) | |
Epigastric/Retrosternal pain | 17 (16.8%) | |
Anorexia | 18 (17.8%) | |
Odynophagia | 12 (11.8%) | |
GI bleeding | 9 (8.9%) | |
Persistent cough | 8 (7.9%) | |
Regurgitation | 4 (4.0%) | |
Hoarseness | 3 (3.0%) | |
Anemia | 2(2.0%) | |
Hepatomegaly | 1(1.0%) | |
Lymphadenopathy | 1 (1.0%) | |
Histological type (n = 110) | ESCC | 54 (49.1%) |
EAC | 56 (50.9%) | |
Stage at diagnosis (n = 84) | I | 8 (9.5%) |
II | 12 (14.3%) | |
III | 50 (59.5%) | |
IV | 14 (16.7%) | |
Grade (n = 93) | Poorly differentiated | 24 (25.8%) |
Moderately differentiated | 61 (65.6%) | |
Well differentiated | 7 (7.5%) | |
Undifferentiated | 1 (1.1%) | |
Location of tumor (n = 101) | Upper esophagus | 20 (19.8%) |
Middle esophagus | 20 (19.8%) | |
Lower esophagus | 29 (28.7%) | |
GE junction | 32 (31.7%) |